Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dynamic Assessments of Molecular Response to Guide Early 177Lu-PSMA-617 Treatment Discontinuation: The DYNAMO Study

NCT07698535 is registered in ClinicalTrials.gov with University of Washington as lead sponsor.

NCT NCT07698535
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07698535 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dynamic Assessments of Molecular Response to Guide Early 177Lu-PSMA-617 Treatment Discontinuation: The DYNAMO Study
Lead sponsor
University of Washington
Phase
Phase 2
Overall status
Recruiting
Start date
October 1, 2026
Completion date
July 5, 2029
Enrollment
64 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic castration-resistant prostate adenocarcinoma, stage ivb prostate cancer ajcc v8